Cargando…

The effect of metabolic syndrome and its components in midpregnancy on neonatal outcomes

Background: The prevalence of metabolic syndrome has been rising worldwide in recent decades. Determining the associations between metabolic syndrome and its components in midpregnancy with neonatal anthropometric indices and outcomes is a major challenge in both public health and clinical care. Met...

Descripción completa

Detalles Bibliográficos
Autores principales: Sourinejad, Hadis, Shayan, Arezoo, Niyati, Shiva, Moghaddam-Banaem, Lida
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iran University of Medical Sciences 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137841/
https://www.ncbi.nlm.nih.gov/pubmed/32280653
http://dx.doi.org/10.34171/mjiri.33.147
_version_ 1783518486298886144
author Sourinejad, Hadis
Shayan, Arezoo
Niyati, Shiva
Moghaddam-Banaem, Lida
author_facet Sourinejad, Hadis
Shayan, Arezoo
Niyati, Shiva
Moghaddam-Banaem, Lida
author_sort Sourinejad, Hadis
collection PubMed
description Background: The prevalence of metabolic syndrome has been rising worldwide in recent decades. Determining the associations between metabolic syndrome and its components in midpregnancy with neonatal anthropometric indices and outcomes is a major challenge in both public health and clinical care. Methods: This prospective cohort study was performed on 238 pregnant women at 24-28 weeks of gestation. Metabolic syndrome was recognized with 3 or more of the following criteria: triglyceride ≥ 247 mg/dL; HDL < 61 mg/dL; GCT ≥ 140 mg/dL; prepregnancy body mass index ≥ 30 kg/m2; and blood pressure ≥ 130/85 mmHg. Statistical analysis was performed through descriptive statistics, including mean, standard deviation, frequency, and percentage, Mann-Whitney test, Chi-square test, Fisher’s exact test, linear and logistic regression in SPSS 21.0. P values < 0.05 were considered significant. Results: There was a significant association between blood hypertriglyceridemia in weeks 24-28 and anthropometric indices, including weight, height, and jaundice, in the first 24 hours of birth. Metabolic syndrome also had a significant relationship with jaundice (P=0.002). The results of linear regression analysis revealed that metabolic syndrome was positively associated with birth weight (B=0.18, P=0.003) and height (B=0.18, P=0.009). Among the components of metabolic syndrome, the results showed a direct relationship between increased blood triglyceride of the mother and newborn’s weight (B=0.11, P=0.011) and height (B=0.14, P=0.007). Also, increased BMI had a significant direct relationship with the newborn’s weight (B=0.11, P=0.023) and height (B=0.12, P=0.023). Moreover, decreased HDL had a significant reverse relationship with the newborn’s weight (B=0.09, P=0.042). Conclusion: Presence of metabolic syndrome and its components in midpregnancy may influence neonatal outcomes, especially anthropometric indices. However, more studies should be conducted to further investigate these relationships.
format Online
Article
Text
id pubmed-7137841
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Iran University of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-71378412020-04-10 The effect of metabolic syndrome and its components in midpregnancy on neonatal outcomes Sourinejad, Hadis Shayan, Arezoo Niyati, Shiva Moghaddam-Banaem, Lida Med J Islam Repub Iran Original Article Background: The prevalence of metabolic syndrome has been rising worldwide in recent decades. Determining the associations between metabolic syndrome and its components in midpregnancy with neonatal anthropometric indices and outcomes is a major challenge in both public health and clinical care. Methods: This prospective cohort study was performed on 238 pregnant women at 24-28 weeks of gestation. Metabolic syndrome was recognized with 3 or more of the following criteria: triglyceride ≥ 247 mg/dL; HDL < 61 mg/dL; GCT ≥ 140 mg/dL; prepregnancy body mass index ≥ 30 kg/m2; and blood pressure ≥ 130/85 mmHg. Statistical analysis was performed through descriptive statistics, including mean, standard deviation, frequency, and percentage, Mann-Whitney test, Chi-square test, Fisher’s exact test, linear and logistic regression in SPSS 21.0. P values < 0.05 were considered significant. Results: There was a significant association between blood hypertriglyceridemia in weeks 24-28 and anthropometric indices, including weight, height, and jaundice, in the first 24 hours of birth. Metabolic syndrome also had a significant relationship with jaundice (P=0.002). The results of linear regression analysis revealed that metabolic syndrome was positively associated with birth weight (B=0.18, P=0.003) and height (B=0.18, P=0.009). Among the components of metabolic syndrome, the results showed a direct relationship between increased blood triglyceride of the mother and newborn’s weight (B=0.11, P=0.011) and height (B=0.14, P=0.007). Also, increased BMI had a significant direct relationship with the newborn’s weight (B=0.11, P=0.023) and height (B=0.12, P=0.023). Moreover, decreased HDL had a significant reverse relationship with the newborn’s weight (B=0.09, P=0.042). Conclusion: Presence of metabolic syndrome and its components in midpregnancy may influence neonatal outcomes, especially anthropometric indices. However, more studies should be conducted to further investigate these relationships. Iran University of Medical Sciences 2019-12-23 /pmc/articles/PMC7137841/ /pubmed/32280653 http://dx.doi.org/10.34171/mjiri.33.147 Text en © 2019 Iran University of Medical Sciences http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution NonCommercial 3.0 License (CC BY-NC 3.0), which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.
spellingShingle Original Article
Sourinejad, Hadis
Shayan, Arezoo
Niyati, Shiva
Moghaddam-Banaem, Lida
The effect of metabolic syndrome and its components in midpregnancy on neonatal outcomes
title The effect of metabolic syndrome and its components in midpregnancy on neonatal outcomes
title_full The effect of metabolic syndrome and its components in midpregnancy on neonatal outcomes
title_fullStr The effect of metabolic syndrome and its components in midpregnancy on neonatal outcomes
title_full_unstemmed The effect of metabolic syndrome and its components in midpregnancy on neonatal outcomes
title_short The effect of metabolic syndrome and its components in midpregnancy on neonatal outcomes
title_sort effect of metabolic syndrome and its components in midpregnancy on neonatal outcomes
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137841/
https://www.ncbi.nlm.nih.gov/pubmed/32280653
http://dx.doi.org/10.34171/mjiri.33.147
work_keys_str_mv AT sourinejadhadis theeffectofmetabolicsyndromeanditscomponentsinmidpregnancyonneonataloutcomes
AT shayanarezoo theeffectofmetabolicsyndromeanditscomponentsinmidpregnancyonneonataloutcomes
AT niyatishiva theeffectofmetabolicsyndromeanditscomponentsinmidpregnancyonneonataloutcomes
AT moghaddambanaemlida theeffectofmetabolicsyndromeanditscomponentsinmidpregnancyonneonataloutcomes
AT sourinejadhadis effectofmetabolicsyndromeanditscomponentsinmidpregnancyonneonataloutcomes
AT shayanarezoo effectofmetabolicsyndromeanditscomponentsinmidpregnancyonneonataloutcomes
AT niyatishiva effectofmetabolicsyndromeanditscomponentsinmidpregnancyonneonataloutcomes
AT moghaddambanaemlida effectofmetabolicsyndromeanditscomponentsinmidpregnancyonneonataloutcomes